Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Soluble HLA in human body fluids.

D Aultman1, I Adamashvili, K Yaturu

  • 1Louisiana State University Medical Center, Shreveport 71130, USA.

Human Immunology
|May 13, 1999
PubMed
Summary

Soluble human leukocyte antigen (sHLA) molecules, particularly sHLA-II, are present in various body fluids like sweat, saliva, and tears. Their presence is normal, but sHLA-II appears to be the predominant form, suggesting different production mechanisms than sHLA-I.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Young people with intellectual disability speak out about life after school: "I want to do more in life than just…be a disability person".

Journal of intellectual & developmental disability·2025
Same author

Co-Producing a Package of Novel Online Resources to Support the Mental Health Needs of People With Persistent Pain: BeeFree.

Musculoskeletal care·2024
Same author

Functional nociceptin receptors are upregulated on human umbilical vein endothelial cells during experimental in vitro sepsis.

British journal of anaesthesia·2024
Same author

MOP and NOP receptor interaction: Studies with a dual expression system and bivalent peptide ligands.

PloS one·2022
Same author

Drug-receptor interactions in anaesthesia.

BJA education·2022
Same author

Economic impact of COVID-19 pandemic on healthcare facilities and systems: International perspectives.

Best practice & research. Clinical anaesthesiology·2021

Area of Science:

  • Immunology
  • Biochemistry

Background:

  • Soluble forms of human leukocyte antigen (sHLA) in serum are well-documented.
  • Limited research exists on sHLA concentrations in other bodily fluids.

Purpose of the Study:

  • To quantify soluble HLA class I (sHLA-I) and soluble HLA class II (sHLA-II) in sweat, saliva, and tears.
  • To investigate sHLA concentrations in cerebrospinal fluid (CSF) from patients with various illnesses.

Main Methods:

  • Solid-phase enzyme-linked immunoassay (ELISA) was used to measure sHLA-I and sHLA-II.
  • Western blotting confirmed sHLA-II presence in saliva.
  • Samples analyzed included sweat, saliva, tears, and CSF.

Main Results:

  • Normal individuals showed very low or undetectable sHLA-I in sweat, saliva, and tears.

Related Experiment Videos

  • sHLA-II was detected in all tested body fluids (sweat, saliva, tears) with individual variations.
  • Elevated sHLA-II in CSF was observed in patients with seizures, neonatal hepatitis, and connective tissue disease with viral infection.
  • High CSF sHLA-I was found in viral encephalitis, while sHLA-II was absent.

    • Conclusions:

    • The presence of sHLA in various body fluids is physiologically normal.
    • sHLA-II is the predominant soluble HLA class in body fluids.
    • Distinct mechanisms likely govern sHLA-II production in body fluids compared to sHLA-I in serum.